Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Bilastine

A second-generation H1 antihistamine developed in Spain, authorised in Europe in 2010 and first launched in Spain in 2011, for allergic rhinoconjunctivitis and urticaria. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?It is practically not metabolised and does not interact with cytochrome P450 enzymes; PET studies show that it occupies very few H1 receptors in the brain.

BilastineGo to the active ingredient →
BilastineActive ingredientBilastineCat. No. P-B081-001CAS 202189-78-4
Bilastine-d4Isotopically labelledBilastine-d4Cat. No. P-B081-003CAS 2747918-37-0
Bilastine-d6Isotopically labelledBilastine-d6Cat. No. P-B081-004CAS 2470116-56-2

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.